Valeant, Ackman Lose In California Court, Must Face Insider Trading ChargesMark Melin
Just when Valeant Pharmaceuticals and Bill Ackman’s Pershing Square thought Andrew Left and Citron Research charges of impropriety were in the rear view mirror – Left announced yesterday he had lightened up on his short position in the stock – another shoe dropped in a California courtroom this week on an unrelated matter.
Valeant, Ackman and Pershing Square must face insider trading lawsuit, judge rules
U.S. District Judge . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible